55052-24-9 = 55052-27-2 + 80235-01-4 + 55052-28-3 反应条件:1.1 Reagents: Methanesulfonyl Chloride Solvents: Dimethylformamide; 1 H,60 - 75 °C; 5 H,70 °C; 70 °C -> 40 °C1.2 Solvents: Water; < 15 °C1.3 Reagents: Sodium Hydroxide Solvents: Water; 0.5 H,10 °C 标题:Highly Regioselective And Practical Synthesis Of 5-Bromo-4-Chloro-3-Nitro-7-Azaindole 作者:Han,Chong; Et Al 参考文献:Organic Process Research & Development 日期:2017 卷标:21(4) 页码:664-668]
16887-60-8 + 504440-63-5 = 55052-27-2 + 80235-01-4 + 55052-28-3 反应条件:1.1 Reagents: Tripotassium Phosphate Solvents: Water; Ph 10,10 - 15 °C; 1 H,0 °C2.1 Reagents: Methanesulfonyl Chloride Solvents: Dimethylformamide; 1 H,60 - 75 °C; 5 H,70 °C; 70 °C -> 40 °C2.2 Solvents: Water; < 15 °C2.3 Reagents: Sodium Hydroxide Solvents: Water; 0.5 H,10 °C 标题:Highly Regioselective And Practical Synthesis Of 5-Bromo-4-Chloro-3-Nitro-7-Azaindole 作者:Han,Chong; Et Al 参考文献:Organic Process Research & Development 日期:2017 卷标:21(4) 页码:664-668]
271-63-6 = 55052-27-2 + 80235-01-4 + 55052-28-3 反应条件:1.1 Solvents: Ethyl Acetate; < 20 °C; 2 H,25 °C2.1 Reagents: Tripotassium Phosphate Solvents: Water; Ph 10,10 - 15 °C; 1 H,0 °C3.1 Reagents: Methanesulfonyl Chloride Solvents: Dimethylformamide; 1 H,60 - 75 °C; 5 H,70 °C; 70 °C -> 40 °C3.2 Solvents: Water; < 15 °C3.3 Reagents: Sodium Hydroxide Solvents: Water; 0.5 H,10 °C 标题:Highly Regioselective And Practical Synthesis Of 5-Bromo-4-Chloro-3-Nitro-7-Azaindole 作者:Han,Chong; Et Al 参考文献:Organic Process Research & Development 日期:2017 卷标:21(4) 页码:664-668
📜7-氮杂吲哚置于水,间氯过氧苯甲酸,六甲基二硅氮烷,Sodium Hydroxide体系中,用 四氢呋喃,甲醇,乙二醇二甲醚 作为反应溶剂,化学反应 8.0H,反应生成 6-氯-7-氮杂吲哚 参考文献: Aryloxyacetylindoles And Analogs As Antibiotic Tolerance Inhibitors[fr] Aryloxyacétylindoles Et Analogues En Tant Qu'Inhibiteurs De Tolérance Aux Antibiotiques 标题: Aryloxyacetylindoles And Analogs As Antibiotic Tolerance Inhibitors[fr] Aryloxyacétylindoles Et Analogues En Tant Qu'Inhibiteurs De Tolérance Aux Antibiotiques 摘要:该披露提供了芳基氧乙酰基吲哚化合物及类似物的化合物和药物组合物,用于治疗慢性和急性细菌感染.其中某些化合物是一般式(I)(i)的化合物或其药用可接受的盐或前药.该披露的某些化合物是mvfr抑制剂.mvfr抑制剂减少抗生素耐药细菌菌株的形成,对治疗革兰氏阴性细菌感染和减少铜绿假单胞菌的毒力有用.该披露还提供了治疗受试者细菌感染的方法,包括铜绿假单胞菌感染.
专利号:US-8252930-B2 优先权日:2006-07-06 标 题:Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition 发明人:STOIT AXEL; COOLEN HEIN K A C; VAN DER NEUT MARTINA A W; KRUSE CORNELIS G 权利人:STOIT AXEL; COOLEN HEIN K A C; VAN DER NEUT MARTINA A W; KRUSE CORNELIS G; SOLVAY PHARM BV 摘要:Azaindole derivatives of formula (I): n nwherein the symbols have the meanings given in the specification, are described. These compounds have a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition. The invention also relates to pharmaceutical compositions containing these compounds, to methods for preparing them, methods for preparing novel intermediates useful for their synthesis, methods for preparing compositions, and uses of such compounds and compositions, for example, their use in administering them to patients to achieve a therapeutic effect in disorders in which nicotinic receptors and/or dopamine transporters are involved, or that can be treated via manipulation of those receptors.
专利号:US-2024360125-A9 优先权日:2021-02-22 标 题 :2-substituted bicyclo[1.1.1]pentanes 发明人:MACMILLAN DAVID W; GARRY OLIVIA L; LIANG YUFAN; HEILMANN MICHAEL 权利人:UNIV PRINCETON 摘要:Provided herein are 2-substituted bicyclo[1.1.1]pentane (BCP) compounds, as well as methods of making the 2-substituted BCP compounds and methods of derivatizing the 2-substituted BCP compounds, particularly at the 2-position. The 2-substituted BCP compounds described herein are useful building blocks in the synthesis of a variety of products, including pharmaceuticals, polymers, liquid crystals, monolayers and supramolecular structures.
专利号:EP-2041131-B1 优先权日:2006-07-06 标 题 :Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition 发明人:STOIT AXEL; COOLEN HEIN K A C; VAN DER NEUT MARTINA A W; KRUSE CORNELIS G 权利人:ABBOTT HEALTHCARE PRODUCTS BV 摘要:The invention concerns azaindole derivatives having the general formula (I) wherein the symbols have the meanings given in the specification. These compounds have a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition. The invention also relates to pharmaceutical compositions containing these compounds, to methods for preparing them, methods for preparing novel intermediates useful for their synthesis, methods for preparing compositions, and uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in disorders in which nicotinic receptors and/or dopamine transporters are involved, or that can be treated via manipulation of those receptors.